Register      Login
Australian Health Review Australian Health Review Society
Journal of the Australian Healthcare & Hospitals Association
Shopping Cart: ( empty )
You are here: Home > Journals > AH > AH08723
RESEARCH ARTICLE
Contents Vol 34(3)

Barriers to comorbidity service delivery: the complexities of dual diagnosis and the need to agree on terminology and conceptual frameworks

Rachel Canaway A and Monika Merkes B C
+ Author Affiliations
- Author Affiliations

A School of Psychology and Psychiatry, Faculty of Medicine, Nursing and Health Sciences, Monash University, Caulfield, VIC 3145, Australia.

B Australian Institute for Primary Care, Faculty of Health Sciences, La Trobe University, Bundoora, VIC 3086, Australia.

C Corresponding author. Email: m.merkes@latrobe.edu.au

Australian Health Review 34(3) 262-268 https://doi.org/10.1071/AH08723
Submitted: 25 November 2008  Accepted: 22 April 2009   Published: 25 August 2010

Abstract

This paper draws from a literature review commissioned as part of a larger project evaluating comorbidity treatment service models, which was funded by the Australian Government Department of Health and Ageing as part of the National Comorbidity Initiative. The co-occurrence of mental health and substance use disorders (comorbidity) is a common and complex problem. This paper outlines conceptual and practical complexities and barriers associated with comorbidity treatment service delivery, particularly around the variable nature of comorbidity, and the impacts of the separation of the mental health (MH) and alcohol and other drug (AOD) sectors with their differing institutional cultures, aetiological concepts, philosophical underpinnings, educational requirements, administrative arrangements, and screening and treatment approaches. Issues pertaining to the lack of consistent definitions and conceptual frameworks for comorbidity are discussed, particularly in relation to the reported lack of communication, collaboration, and linkages between the sectors. It is suggested that the adoption of consistent terminology and conceptual frameworks may provide a valuable step towards consistency in service provision and research and could lead to improved capacity to address the many issues relating to comorbidity service provision and treatment efficacy.

What is known about the topic? The co-occurrence of mental health and substance use disorders (comorbidity) is a common and complex problem. However, the service system is not sufficiently developed and coordinated to serve clients with comorbid problems well.

What does this paper add? This paper summarises the issues pertaining to conceptual and practical complexities and barriers associated with comorbidity treatment service delivery, including the different aetiologies of comorbidity and types and settings of service providers.

What are the implications for practitioners? There is a need for practitioners and other stakeholders to agree on consistent terminology and framework(s) relevant to comorbidity to overcome the barriers and complexities that currently limit service delivery and access to treatment.


Acknowledgements

This paper is based on a literature review undertaken with funding from the Australian Government Department of Health and Ageing, as part of the Comorbidity Treatment Service Model Evaluation project. The authors acknowledge Professor Hal Swerissen for providing comments on a draft of this article. The opinions expressed in this document are those of the authors and are not necessarily those of the Australian Government.


References


[1] Hall W , Lynskey M , Teesson M . What is comorbidity and why does it matter? In: Teesson M, Burns L, Eds. National comorbidity project. Canberra: Commonwealth Department of Health and Aged Care; 2001: pp. 11–7.

[2] Minkoff K . Comprehensive Continuous Integrated System Care (CCISC): Psychopharmacology practice guidelines for individuals with co-occurring psychiatric and substance use disorders (COD); 2005. Available at http://www.bhrm.org/guidelines/ddguidelines.htm [verified February 2008].

[3] Croton G . Co-occurring mental health and substance use disorders: an investigation of service system modifications and initiatives designed to provide an integrated treatment response; 2004. Available at http://www.dualdiagnosis.org.au/Croton_Fellowship_Co-occurring%20Disorders.pdf [verified February 2008].

[4] Teesson M , Proudfoot H (Eds). Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Australian Government Department of Health and Ageing; 2003.

[5] Jané-Llopis E,  Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25(6): 515–36.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 6 July 2010].

[8] Holt M , Treloar C , McMillan K , Schultz L , Schultz M , Bath N . Barriers and incentives to treatment for illicit drug users with mental health comorbidities and complex vulnerabilities. 2007; Monograph Series No. 61. Available at http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mono61 [verified March 2008].

[9] Croton G . Australian treatment system’s recognition of and response to co-occurring mental health and substance use disorders – a submission to the 2005 Senate Select Committee on Mental Health; 2005. Available at http://www.dualdiagnosis.org.au/home/index.php?option=com_docman&task=cat_view&gid=29&Itemid=27 [verified March 2008].

[10] Cole M,  Sacks T. When dual diagnosis means no diagnosis: co-occurring mental illness and problematic drug use in clients of alcohol and drug services in eastern metropolitan Melbourne. Mental Health and Substance Use. Dual Diagnosis 2008; 1(1): 33–43.
| Crossref | GoogleScholarGoogle Scholar | [verified March 2008].

[23] Osher FC,  Drake RE. Reversing a history of unmet needs: approaches to care for persons with co-occurring addictive and mental disorders. Am J Orthopsychiatry 1996; 66(1): 4–11.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified April 2008].

[30] Kavanagh DJ,  Greenaway L,  Jenner L,  Saunders JB,  White A,  Sorban J, et al. Contrasting views and experiences of health professionals on the management of comorbid substance misuse and mental disorders. Aust N Z J Psychiatry 2000; 34(2): 279–89.
| PubMed | [verified March 2008].

[38] Siggins Miller Consultants. Current practice in the management of clients with comorbid mental health and substance use disorders in tertiary care settings. Canberra: Commonwealth Department of Health and Ageing; 2003.

[39] Department of Health. Mental health policy implementation guide: dual diagnosis good practice guide; 2002. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009058 [verified April 2008].

[40] Todd J,  Green G,  Harrison M,  Ikuesan BA,  Self C,  Baldacchino A, et al. Defining dual diagnosis of mental illness and substance misuse: some methodological issues. J Psychiatr Ment Health Nurs 2004; 11(1): 48–54.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified May 2008].

[49] DiClemente CC,  Nidecker M,  Bellack AS. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. J Subst Abuse Treat 2008; 34(1): 25–35.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[50] Carey KB,  Maisto SA,  Carey MP,  Purnine DM. Measuring readiness-to-change substance misuse among psychiatric outpatients: reliability and validity of self-report measures. J Stud Alcohol 2001; 62(1): 79–88.
| PubMed |

[51] Richmond I,  Foster J. Negative attitudes towards people with co-morbid mental health and substance misuse problems: an investigation of mental health professionals. J Ment Health 2003; 12(4): 393–403.
| Crossref | GoogleScholarGoogle Scholar |

[52] Proudfoot H , Deady M , Mills KL . National comorbidity clinical guidelines – a literature review. Canberra: Australian Government Department of Health and Ageing unpublished.